U.S. Physical Therapy Inc USPH Stock Analysis
- NYSE
- Stock
- Market closed · opens Monday 9:30 AM ET
$99.49 up $2.29, 2.36% at close Nov 6
Last close · Previous close $97.20
- Market cap
- $1.51BAt the Nov 6 close
- P/E ratio
- 552.72On last 12 months’ EPS
- Diluted EPS
- $0.18Last 12 months
- Dividend yield
- 1.84%Last 12 months
Price chart
$99.49up $2.29, 2.36%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$97.20Nov 5
- Volume295.07KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume180.86KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $58.19 to $101.18; now $99.49
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
USPH beat the S&P 500 in 4 of 7 periods.
| Period | USPH and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | USPH: up 19.0% S&P 500: down 5.6% | USPH beat the S&P 500 by 24.6 percentage points Beat |
| 3M | USPH: up 30.9% S&P 500: down 4.1% | USPH beat the S&P 500 by 35.0 percentage points Beat |
| YTD | USPH: up 29.9% S&P 500: up 8.7% | USPH beat the S&P 500 by 21.2 percentage points Beat |
| 1Y | USPH: up 31.6% S&P 500: up 10.9% | USPH beat the S&P 500 by 20.7 percentage points Beat |
| Long term | ||
| 3Y | USPH: up 24.8% S&P 500: up 75.0% +7.7% vs +20.5% a year | USPH trailed the S&P 500 by 50.2 percentage points Trailed |
| 5Y | USPH: up 1.0% S&P 500: up 67.8% +0.2% vs +10.9% a year | USPH trailed the S&P 500 by 66.8 percentage points Trailed |
| 10Y | USPH: up 107.9% S&P 500: up 313.1% +7.6% vs +15.2% a year | USPH trailed the S&P 500 by 205.2 percentage points Trailed |
$10,000 invested in USPH 10 years ago (Nov 4, 2016) would be worth about $20,785 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
USPH beat the S&P 500 in 4 of 7 periods.
| Period | USPH and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | USPH: up 19.0% S&P 500: down 5.6% | USPH beat the S&P 500 by 24.6 percentage points Beat |
| 3M | USPH: up 30.1% S&P 500: down 4.3% | USPH beat the S&P 500 by 34.4 percentage points Beat |
| YTD | USPH: up 27.4% S&P 500: up 7.8% | USPH beat the S&P 500 by 19.6 percentage points Beat |
| 1Y | USPH: up 28.3% S&P 500: up 9.7% | USPH beat the S&P 500 by 18.6 percentage points Beat |
| Long term | ||
| 3Y | USPH: up 16.8% S&P 500: up 68.8% +5.3% vs +19.1% a year | USPH trailed the S&P 500 by 52.0 percentage points Trailed |
| 5Y | USPH: down 8.7% S&P 500: up 56.9% −1.8% vs +9.4% a year | USPH trailed the S&P 500 by 65.6 percentage points Trailed |
| 10Y | USPH: up 79.3% S&P 500: up 252.6% +6.0% vs +13.4% a year | USPH trailed the S&P 500 by 173.3 percentage points Trailed |
$10,000 invested in USPH 10 years ago (Nov 4, 2016) would be worth about $17,926 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$147.00
Closing high on . Now 32.3% below that record.
Split-adjusted daily closes since May 29, 1992.
Stock splits
2
Latest: 3-for-2 on . One share bought before the first split is 3 shares today.
Both splits
- 3-for-2
- 2-for-1
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
552.7×The Nov 6 close ÷ diluted EPS over the last 12 months ($0.18)
The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.
USPH trades at 552.7× its earnings over the last 12 months, above its 5-year high of 66.0×. In plain terms, buyers are paying about $553 for each $1 of profit from the past year. How to read P/E
Other valuation measures
- 1.9×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 3.4×Book value as of Jun 30, 2026
Price relative to accounting equity (book value) per share on the Jun 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 22.6×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 4.23%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $1.88BAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own USPH DCF in Excel. Value U.S. Physical Therapy with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $812.20Mup 11.3%
- Net income
- $32.23Mdown 15.6%
- Diluted EPS
- $0.18down 92.1%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $168.03M | $6.63M | $0.39 |
| Q4 FY24 (Dec 31, 2024) | $180.45M | $9.24M | $0.52 |
| Q1 FY25 (Mar 31, 2025) | $183.79M | $9.90M | $0.80 |
| Q2 FY25 (Jun 30, 2025) | $197.34M | $12.39M | $0.58 |
| Q3 FY25 (Sep 30, 2025) | $197.13M | $13.14M | $0.48 |
| Q4 FY25 (Dec 31, 2025) | $202.73M | $4.15M | −$0.43 |
| Q1 FY26 (Mar 31, 2026) | $198.29M | $5.04M | −$0.12 |
| Q2 FY26 (Jun 30, 2026) | $214.06M | $9.90M | $0.25 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $495.02M | $40.83M | $2.41 |
| FY22 (Dec 31, 2022) | $553.14M | $32.16M | $2.25 |
| FY23 (Dec 31, 2023) | $604.80M | $28.24M | $1.28 |
| FY24 (Dec 31, 2024) | $671.35M | $31.42M | $1.84 |
| FY25 (Dec 31, 2025) | $780.99M | $39.58M | $1.42 |
Margins
- Gross 18.7%
- Operating 9.4%
- Net 4.0%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $64.07MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$83.05MLast 12 months
- Capital spending$18.98MLast 12 months
- 7.9%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $24.80MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$27.56MLast 12 months
- Total returned$52.35MLast 12 months
82% of free cash flow
Balance sheet
- $37.60MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$385.79MAs of Jun 30, 2026
- Net debt$348.19MAs of Jun 30, 2026
- 1.27As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.86As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 5 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✗Long-term debt fell relative to assets: not passed
- ✓Current ratio improved: passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- 6.8%Last 12 months
Over the last 12 months, U.S. Physical Therapy’s net income was 6.8% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 2.6%Last 12 months
Over the last 12 months, U.S. Physical Therapy’s net income was 2.6% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.68 |
| 2017 | $0.80 |
| 2018 | $0.92 |
| 2019 | $1.14 |
| 2020 | $0.32 |
| 2021 | $1.46 |
| 2022 | $1.64 |
| 2023 | $1.72 |
| 2024 | $1.76 |
| 2025 | $1.80 |
| 2026 (to date) | $1.38 |
Dividend details
- $1.83Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- 1.84%; 5-yr low 0.96%, 5-yr high 3.66%Last 12 months
Dividends paid over the last 12 months as a share of the Nov 6 close. The bar shows where that yield sits in its range over the past five years; the median was 1.93%.
- $0.46Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyQuarterly4 payments in the last 12 months
- 4 yearsThrough 2025
How many calendar years in a row the full-year amount has risen, through 2025.
- 1,016.7%Last 12 months
The share of earnings paid out as dividends over the last 12 months. Lower ratios leave more room to reinvest or raise the dividend.
Payout = Dividends per share ÷ Diluted EPS (both last 12 months)Payout ratio calculator
About U.S. Physical Therapy Inc
U.S. Physical Therapy, Inc. through its subsidiaries, operates outpatient physical and occupational therapy clinics that provides pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company also operates two clinics, which specialize in the outpatient, non-surgical treatment of osteo arthritis degeneration joint disease and other musculoskeletal conditions and perform certain services on behalf of third parties that provide physical therapy services. In May 2013, the Company acquired an 80% interest in a five clinic physical therapy group. In October 2013, U.S. Physical Therapy Inc announced that it has sold the remaining piece of its former Physician Services business.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Texas, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- NYSE
- Asset type
- Common stock
- Price history since
USPH news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
USPH stock FAQ
What is USPH stock’s price today?
U.S. Physical Therapy (USPH) traded at $99.49 at the close on , up $2.29 (2.36%) from the previous close of $97.20. Over the past 52 weeks it has traded between $58.19 and $101.18.
If you invested $1,000 in USPH 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in USPH on would be worth about $2,079 at the close on , a total return of +107.9%. The same $1,000 would be worth $1,010 if invested five years ago, $1,316 if invested one year ago, $11,338 if invested 20 years ago, and $39,567 if invested 30 years ago. Past performance doesn’t predict future returns.
What is U.S. Physical Therapy’s market cap?
U.S. Physical Therapy’s market capitalization is about $1.5 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $99.49 (how market cap works). U.S. Physical Therapy reported 15.22M shares outstanding at the end of its latest quarter ().
What is USPH’s P/E ratio?
USPH trades at 552.7 times its diluted earnings over the four quarters to ($0.18 per share), at the close. Over the past five years its P/E has ranged from 23.1 to 66.0, with a median of 36.7. (How the P/E ratio works.)
How much revenue does U.S. Physical Therapy make?
U.S. Physical Therapy reported $812.2 million of revenue over the four quarters to , up 11.3% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $214.1 million, up 8.5% from a year earlier.
Is U.S. Physical Therapy profitable?
Yes. U.S. Physical Therapy earned $32.2 million of net income over the four quarters to , a net margin of 4.0%, and its operating margin was 9.4% (what margins tell you).
What are USPH’s earnings per share?
USPH’s diluted earnings per share were $0.18 over the four quarters to , compared with $2.29 in the twelve months before. The latest quarter (Q2 FY26) brought $0.25 per share, against $0.58 a year earlier (how EPS works).
Does USPH pay a dividend?
Yes. U.S. Physical Therapy pays a quarterly dividend. The most recent was $0.46 per share, with an ex-dividend date of . Over the last twelve months it paid $1.83 per share, a 1.84% yield at the close, and the full-year dividend has risen 4 years in a row (how dividend yield works).
Based on the last 12 months’ payments ($1.83 per share), and if the next 12 months match the last 12, 100 shares would receive about $183 over 12 months, and $1,000 over 12 months would take about 547 shares, roughly $54,421 at the close. Dividends can change.
What is USPH’s 52-week high and low?
Over the past 52 weeks USPH has traded as low as $58.19 and as high as $101.18. At $99.49 at the close on , it is 1.7% below that high and 71.0% above the low.
What is USPH’s all-time high?
USPH’s highest closing price was $147.00 on , adjusted for stock splits. At $99.49 at the close on , it is 32.3% below that record.
Has USPH stock ever split?
Yes, twice: 2-for-1 on ; 3-for-2 on . One share bought before the first split would be 3 shares today.
How has USPH stock performed?
Including dividends and measured to the close on , USPH has returned +29.9% so far this year and +31.6% over the past year, and +1.0% over five years (+0.2% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is U.S. Physical Therapy in?
U.S. Physical Therapy is in the Healthcare sector and the Medical Care Facilities industry, and is headquartered in Texas, USA.
What exchange does USPH trade on?
U.S. Physical Therapy trades on the NYSE under the ticker symbol USPH. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.